Gastrointestinal surgery for the morbid obese has long been an option in treatment, providing positive long-lasting results such as normal blood glucose and glycosylated hemoglobin levels and the discontinuation of diabetes-related medications. Is type 2 diabetes an operable intestinal disease? Join host Dr. Steven Edelman and his guest, chief of gastrointestinal metabolic surgery at Weill Cornell Medical College, Dr. Francesco Rubino, as they discuss the implications of metabolic surgery for type 2 patients.
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Gastric Surgery for Bypassing Type 2 Diabetes
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Presenters
Recommended
Details
Presenters
Comments
Recommended
Overview
Gastrointestinal surgery for the morbid obese has long been an option in treatment, providing positive long-lasting results such as normal blood glucose and glycosylated hemoglobin levels and the discontinuation of diabetes-related medications. Is type 2 diabetes an operable intestinal disease? Join host Dr. Steven Edelman and his guest, chief of gastrointestinal metabolic surgery at Weill Cornell Medical College, Dr. Francesco Rubino, as they discuss the implications of metabolic surgery for type 2 patients.
Presenters
Facebook Comments